Deshaies Robert Joseph sold $297K of WEX

Deshaies Robert Joseph (COO, Benefits) sold 2,000 shares of WEX Inc. (WEX) at an average of $148.40 ($143.46–$149.77, $0.30M total) across 6 trades on 2026-07-06 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Deshaies Robert Joseph
Published Jul 8, 2026, 9:23 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 8, 2026, 9:25 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$WEX
Neutral
high confidence
Mentioned
$WEX
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$WEXNeutralLow
01

Why it matters

The disclosure updates the record of insider activity but does not provide new operational, financial, or regulatory information about WEX.

02

Market read

Traders may treat this as routine insider activity with limited immediate impact, but it can be used to track insider sentiment trends.

03

What to watch

The article provides no context on total insider holdings, option exercises, or whether other insiders sold/bought around the same window.

Relevance 3/10Novelty 3/10Timing: Filed after-hours on 2026-07-08, covering sales dated 2026-07-06.

Background

This is an SEC Form 4 insider transaction for WEX, reported by the COO of Benefits, Robert Joseph Deshaies.

Company-level read

Ticker impact

$WEXNeutralHigh confidence
Context

WEX COO Deshaies sold about $296.8K of WEX shares via an open-market sale under a pre-arranged 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move solely from this Form 4.

Evidence & confidence

The filing is a Form 4 insider transaction, explicitly tied to a pre-arranged 10b5-1 plan, and the disclosed sale size is modest versus typical large-cap trading flows.

Market effects

No clear sector read-through from a single planned insider sale.

None indicated.

None indicated.

Counterpoint

Even planned 10b5-1 sales can coincide with internal views on near-term risk, so traders may still monitor for follow-on selling or changes in insider behavior.

Key entities

  • WEX Inc.

    Company whose shares were sold by an insider under a 10b5-1 plan.

  • Deshaies Robert Joseph

    COO, Benefits at WEX, reported an open-market sale of 2,000 shares across six trades.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$WEXMed

WEX Extends Credit Facilities to 2031, Boosting Revolver to $1.7 Billion

WEX amended its credit agreement, extending the maturity of its revolving credit facility and tranche A term loans to 2031. The revolving commitments increased to $1.7 billion, and the tranche A term loan facility to $900 million. The amendment also repriced interest margins based on the company's leverage ratio, enhancing WEX's financing flexibility and liquidity.

$WEXHighAI 8/10

WEX Q3 2026 presentation: strong beat, raised guidance, stock slips

WEX Inc. reported Q3 2026 revenue of $780.1M and adjusted EPS of $6.13, beating estimates. Despite raising full-year guidance, shares fell 1.56%. Growth was partly driven by fuel prices and FX, with organic revenue up 4.4%. Mobility segment led growth, while Corporate Payments faced headwinds. The company maintained strong cash flow and repurchased $200M in shares.

$WEXMedAI 8/10

WEX Q3 Earnings Call Highlights

WEX reported Q3 adjusted operating margin expansion of 310 basis points, driven by higher fuel prices. Mobility revenue grew 20.6%, with organic growth accelerating to 4.4%. The company raised its full-year Mobility organic revenue growth forecast to 3%-5%. Benefits revenue rose 4.8% to $207.6M, while Corporate Payments revenue increased 3.5% to $137.4M. WEX updated its Q4 and full-year outlooks, expecting 5% organic revenue growth and 18% EPS growth excluding macro factors.

$WEXMed

WEX Inc (WEX) (Q3 2026) Earnings Call Highlights: Record Revenue

WEX Inc (WEX) reported Q3 2026 earnings with record revenue but lowered full-year Corporate Payments growth guidance to 4%-6% due to Middle East travel disruptions and delayed embedded payments. Benefits segment SaaS account growth slowed to 2.8%, and Mobility volumes were softer due to high diesel prices. Interest rates dragged on Benefits revenue, and Q4 credit losses are expected to rise.

$WEXHighAI 8/10

WEX (WEX) Q3 2026 Earnings Call Transcript

WEX reported Q3 2026 earnings with record revenue of $780.1M (+12.8% YoY) and adjusted EPS of $6.13 (+33.6% YoY). Organic growth was 4.4%, with AI initiatives and higher fuel prices contributing to performance. The company repurchased $200M in shares, reflecting strong cash generation. WEX highlighted progress in mobility, benefits, and corporate payments segments, emphasizing AI-driven innovations and strategic investments.